These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 454955)

  • 1. The anti-sickling activity of a series of aromatic aldehydes [proceedings].
    Beddell CR; Kneen G; White RD
    Br J Pharmacol; 1979 May; 66(1):70P. PubMed ID: 454955
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of anti-adhesive drugs on red cell sickling in vitro.
    Bicher HI; Padilla F; Van Wagner WH
    Bibl Anat; 1975; 13():127-8. PubMed ID: 1231698
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of sickling in vitro by sodium naproxen.
    Rooks WH; Kennedy C; Glenn O; Carter A
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):421-2. PubMed ID: 4852483
    [No Abstract]   [Full Text] [Related]  

  • 4. Viscosity and filtrability measurements of sickle-cell suspensions in the development of anti-sickling drugs.
    Ohnishi ST
    Blood Cells; 1982; 8(1):79-87. PubMed ID: 7115980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light scattering studies of retardation of sickling by aspirin-like drugs.
    Rabinowitz IN; Wolf PL; Berman S
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):417-20. PubMed ID: 4852998
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of a 'sickling pulse' on the calcium and potassium permeabilities of intact, sickle trait red cells [proceedings].
    Bookchin RM; Lew VL
    J Physiol; 1978 Nov; 284():93P-94P. PubMed ID: 731601
    [No Abstract]   [Full Text] [Related]  

  • 7. Adaptation of the ektacytometer to automated continuous pO2 changes: determination of erythrocyte deformability in sickling disorders.
    Bessis M; Feo C; Jones E; Nossal M
    Cytometry; 1983 Jan; 3(4):296-9. PubMed ID: 6822150
    [No Abstract]   [Full Text] [Related]  

  • 8. Antisickling effects of membrane-interacting compounds.
    Ohnishi ST
    Blood Cells; 1982; 8(2):337-43. PubMed ID: 6130805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glyceraldehyde on the structural and functional properties of sickle erythrocytes.
    Nigen AM; Manning JM
    J Clin Invest; 1978 Jan; 61(1):11-9. PubMed ID: 618907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rate of sickling of cells containing sickle-cell haemoglobin.
    Rampling MW; Sirs JA
    Clin Sci Mol Med; 1973 Nov; 45(5):655-64. PubMed ID: 4759512
    [No Abstract]   [Full Text] [Related]  

  • 11. Sickling of sickle erythrocytes does not alter phospholipid asymmetry.
    Raval PJ; Allan D
    Biochem J; 1984 Oct; 223(2):555-7. PubMed ID: 6497863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protective effect of buflomedil hydrochloride on erythrocyte sickling. In vitro study].
    Briguglio F; Briguglio E; Di Marco V
    Minerva Med; 1986 Feb; 77(7-8):249-62. PubMed ID: 3951731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical and biological aspects of the inhibition of red blood cell sickling by cyanate.
    Manning JM; Cerami A; Gillette PN; De Furia FG; Miller DR
    Adv Exp Med Biol; 1972; 28():253-60. PubMed ID: 5085171
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyanate effect on sickling.
    Charache S; Milner PF
    N Engl J Med; 1972 Dec; 287(26):1357-8. PubMed ID: 4635027
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolation and characterisation of an antisickling agent from Fagara zanthoxyloides root.
    Sofowora EA; Isaac-Sodeye WA; Ogunkoya LO
    Lloydia; 1975; 38(2):169-71. PubMed ID: 1134214
    [No Abstract]   [Full Text] [Related]  

  • 16. The occurrence of lysosome-like structures in sickling erythrocytes.
    Schaeffer K; Brinkley BR; Young JE; Oliver SS; Chang JP; Guillen WM
    Lab Invest; 1970 Sep; 23(3):297-301. PubMed ID: 5459987
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitation of red cell deformability during progressive deoxygenation and oxygenation in sickling disorders (the use of an automated Ektacytometer).
    Bessis M; Feo C; Jones E
    Blood Cells; 1982; 8(1):17-28. PubMed ID: 7115975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-sickling potential of a Nigerian herbal formula (ajawaron HF) and the major plant component (Cissus populnea L. CPK).
    Moody JO; Ojo OO; Omotade OO; Adeyemo AA; Olumese PE; Ogundipe OO
    Phytother Res; 2003 Dec; 17(10):1173-6. PubMed ID: 14669251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickle cell disease: advances in the 1970s and challenge in the 1980s.
    Bunn HF
    Am J Pediatr Hematol Oncol; 1982; 4(2):166-71. PubMed ID: 6180652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of aspirin on sickling and oxygen affinity of erythrocytes.
    De Furia FG; Cerami A; Bunn HF; Lu YS; Peterson CM
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3707-10. PubMed ID: 4521198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.